Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli. - Wikidata - awgldk - TriplyDB

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

http://www.wikidata.org/entity/Q39499156

about

Regulation of Bim in Health and Disease Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity.Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinoma.A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib.Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line.A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.Dovitinib induces mitotic defects and activates the G2 DNA damage checkpoint.Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells.OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.18β-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice.Flavonoid-enriched apple fraction AF4 induces cell cycle arrest, DNA topoisomerase II inhibition, and apoptosis in human liver cancer HepG2 cells.Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma.Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.Small-molecule inhibitor sorafenib regulates immunoreactions by inducing survival and differentiation of bone marrow cells.Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib.Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study.

P2860

Q26781203-84F0013F-8F40-49EE-B8F4-6FB0C03A9A83 Q33728138-B73F5E57-6E58-4205-BB86-95FD8E4C02EF Q34098446-1E25966B-D8F1-4B35-B374-A72F44DF0263 Q34159310-4D5E4D15-4229-405E-B775-FE2C003AFC2E Q36844274-CB6B6A85-B658-406A-BAC4-C97138D82FFA Q36901967-A136CE9B-3B2F-42D7-9E15-624CB4BAA1AF Q37137407-B6C4A781-6B0B-4C4D-A323-D7FEF5FA1E5F Q37301893-DACEB41C-F731-4142-8102-520746AE0C17 Q38632417-D2A76966-9843-43A0-9922-21E36F50AA2B Q38695636-75AFFCAB-0372-4FDD-9D5F-11A2C46BEDF7 Q38764893-115A86CD-36BF-4967-B8A8-5C78EEDD7995 Q38996046-312D0CC8-BE3A-464C-ADB6-0E48B6E3E1B1 Q39179266-6A53C94A-276A-4326-92E1-4CA662440235 Q41923223-8B2094F6-DFF0-4FDF-965A-2A2B35597E4A Q42105382-02916555-F6E8-4CF4-8C73-31D0F09EEED1 Q42362014-FEE1FBBC-8D43-4A60-B932-061DEE4E162E Q44044385-AA4BB00E-5C77-4547-A088-AFC9CCD31A8F Q44998050-6922D531-0DA9-4FFA-80E4-3728FC651AA4 Q47237374-291A7C29-5C57-44F2-87D1-698A991E6E47 Q47378147-69B55539-2D87-4506-A28F-3CFF6CB11AC3 Q51627647-80649426-D527-4DB9-B017-3BA7FC951574 Q52571263-A427735E-0218-480D-AE3B-3B2391CB7138 Q53083316-FB1BAC00-3D58-494D-AB11-C3F4A98F2035 Q54489566-084B1B7D-F18F-4095-BFB1-0E3C6BB7AC95

P2860

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

http://www.wikidata.org/entity/Q39499156

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

@en

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

@nl

type

label

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

@en

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

@nl

prefLabel

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

@en

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

@nl

P1433

Q39499156-E184BD27-832F-4ABA-8F35-956224CC5906

P1476

Q39499156-055A33F3-55C7-4F41-B35A-EF9D6AF74AD0

P2093

Q39499156-39F16394-EA83-4A19-A698-655242A8360A

Q39499156-43EE4CB0-1709-4B44-A607-FC1F9C463BFC

Q39499156-60B296E4-AC1B-4A79-A20E-42F8C85E75FA

Q39499156-6306F116-6578-4A63-B38D-3F0FD274FDD6

Q39499156-AA0E0C95-740D-4200-9522-06CACBA02E09

P2860

Q39499156-09FA73B8-70DC-44D8-A96C-8607DF9931D3

Q39499156-0B646C4C-4029-455E-9E42-6575ABE5FAD8

Q39499156-0C5DE2AF-2BD2-49BD-B223-898B257F5468

Q39499156-13C3BF51-35CD-498D-A6FE-109B5FBE157A

Q39499156-1AD8F760-2E01-43EC-B18A-49B11237F854

Q39499156-20C192D0-0A57-4359-ACA5-A84FFB2E3897

Q39499156-220311E5-FEC0-4A93-A9A1-D49D509BED9D

Q39499156-2E7FDB36-2474-4010-A556-3544039380BF

Q39499156-3EA60D7A-21B3-4769-8F14-B0E5265A958E

Q39499156-4ECCDD96-1B4B-4C8C-B3C1-5985D1C5E5FB

P304

Q39499156-F4157E70-7CA4-4862-B78E-18242B6B3EBF

P31

Q39499156-99F7F74C-44EF-43A7-8569-65E442437C5C

P356

Q39499156-90AC4779-0291-45BF-BD0D-7D558BE4A59C

P433

Q39499156-027F69FC-201D-4DDE-8605-22AEC8D0F03C

P478

Q39499156-D95F2921-8273-4896-8818-3826B33625C7

P50

Q39499156-5A68A54F-8338-471F-98F7-C534B8E05894

Q39499156-93FBF5D1-78E7-470D-AB6C-B3E553C94E01

Q39499156-FC206CB9-B088-4071-866B-A5B18CF3CC30

P577

Q39499156-3D114110-95C5-422C-AA02-1B334F2334CF

P5875

Q39499156-B281296C-8441-420B-AF25-5FE063907498

P698

Q39499156-F7210618-9A33-43D6-A990-3E440E117344

P921

Q39499156-7257C33A-CA2D-48D8-8E2E-0221FEA114D3

P932

Q39499156-06D598CF-854B-40DE-A67C-1661836A1A45

P356

P1433

Journal of Cellular Physiology

P1476

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli

@en

P2093

Jean S Campbell

http://www.w3.org/2001/XMLSchema#string

Joan Fernando

http://www.w3.org/2001/XMLSchema#string

José L Lledó

http://www.w3.org/2001/XMLSchema#string

Laia Caja

http://www.w3.org/2001/XMLSchema#string

Nelson Fausto

http://www.w3.org/2001/XMLSchema#string

P2860

PUMA, a potent killer with or without p53

Responses of Nontransformed Human Hepatocytes to Conditional Expression of Full-Length Hepatitis C Virus Open Reading Frame

Sorafenib in advanced hepatocellular carcinoma

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.

Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond.

P304

1319-1325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.22843

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

227

http://www.w3.org/2001/XMLSchema#string

P50

Isabel Fabregat

Patricia Sancho

Conrado M Fernandez Rodríguez

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51157783

http://www.w3.org/2001/XMLSchema#string

P698

21604268

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3227741

http://www.w3.org/2001/XMLSchema#string